Health
SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months – News-Medical.Net
A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated…
As the coronavirus disease 2019 (COVID-19) pandemic continues to take a heavy toll on the world population, scientists are seeking to identify the protective impact of prior infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
…
Continue Reading
-
Noosa News15 hours agoFather found stabbed dead upstairs at teenagers’ Brisbane house party
-
Noosa News15 hours agoSA ban on plastic produce stickers on hold as growers struggle with costs
-
General15 hours agoJim Chalmers will have to juggle competing demands to secure tax reform
-
Noosa News10 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store